Relapsed acute lymphoblastic leukemia: back to the drawing board

Related Experiment Video

Updated: Sep 17, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.7K

Elad Jacoby1

  • 1Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Hashomer Israel; Gray Faculty of Medical and Health Sciences, Aviv University, Aviv. elad.jacoby@sheba.health.gov.il.

Haematologica
|July 3, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.2K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K

Related Experiment Videos

Last Updated: Sep 17, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.7K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.2K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506

Articles linked to this work by shared authors, journal, and citation graph.

Recovery of a CMV-Reactive TCR from a Clinical Virus-Specific T-Cell Product for Generation of a Defined TCR-T Cell Product.

Transplantation and cellular therapy·2026

Pretransplant infection associated with inferior survival after TCRαβ/CD19-depleted haploidentical HSCT in pediatric nonmalignant disorders.

Cytotherapy·2026

Plasticity under pressure: biology and detection of lineage switch in acute leukemia.

Leukemia·2026

CAR-T as a salvage treatment in polyrefractory RA.

Rheumatology (Oxford, England)·2026

Engineered mRNA backbones for gene expression in human T cells.

Molecular therapy. Nucleic acids·2026

Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.

Rheumatology (Oxford, England)·2026

Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2.

Haematologica·2026

Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomab.

Haematologica·2026

Salvage-free, transplantation-free survival: a proposal for a new clinical endpoint in acute myeloid leukemia.

Haematologica·2026

Platelet and megakaryocyte function in the pathogenesis of POEMS syndrome.

Haematologica·2026

Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantation.

Haematologica·2026

CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantation.

Haematologica·2026

Increased Left Ventricular Wall Thickness without Increased Mechanical Dispersion: A Distinguishing Feature of Transthyretin Amyloidosis Cardiomyopathy.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026

Peripartum cardiomyopathy and antiphospholipid syndrome: a rare association revealed by a right ventricular thrombus. A case report.

Archivos peruanos de cardiologia y cirugia cardiovascular·2026

Highly vascularized left atrial myxoma mimicking a cardiac haemangioma: a case report.

European heart journal. Case reports·2026

High-definition thoracoscopic visualization of the apical pleuropulmonary vascular bridge in spontaneous hemopneumothorax.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques·2026

Ticagrelor Monotherapy Across Korean Body Mass Index Categories in Acute Coronary Syndrome: A Pooled Patient-Level Analysis of the TICO and T-PASS Trials.

Korean circulation journal·2026

Occlusion myocardial infarction without ST-elevation is associated with delayed angiography and a higher risk of cardiovascular events.

Cardiovascular revascularization medicine : including molecular interventions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us